Craig Ritchie

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease

Craig Ritchie, Ashley I. Bush, Andrew Mackinnon et al. · Archives of Neurology · 2003 · 982 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

Ruth Peters, Nigel Beckett, Françoise Forette et al. · The Lancet Neurology · 2008 · 773 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +13

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Robert Howard, Rupert McShane, James Lindesay et al. · New England Journal of Medicine · 2012 · 766 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial

Lars Lannfelt, Kaj Blennow, Henrik Zetterberg et al. · The Lancet Neurology · 2008 · 712 citations

Medicine, Neuroscience, Pharmacology +17